EXEL vs NBIX
Exelixis, Inc. - Common Stock · Neurocrine Biosciences, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | EXEL | NBIX |
|---|---|---|
| Price | $60.99 | $135.91 |
| Market Cap | $15.11B | $13.82B |
| P/E | 19.31 | 28.87 |
| P/B | 8.20 | 3.74 |
| P/S | 6.51 | 4.83 |
| ROE | 42.4% | 13.0% |
| Net Margin | 33.7% | 16.7% |
| Gross Margin | — | — |
| Revenue Growth | 7.0% | 21.4% |
| Dividend Yield | — | — |
| EPS | $3.16 | $4.71 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.